Literature DB >> 32611727

KLRG1+ Memory CD8 T Cells Combine Properties of Short-Lived Effectors and Long-Lived Memory.

Kristin R Renkema1,2, Matthew A Huggins1,2, Henrique Borges da Silva1,2, Todd P Knutson3, Christy M Henzler3, Sara E Hamilton4,2.   

Abstract

CD8 effector T cells with a CD127hi KLRG1- phenotype are considered precursors to the long-lived memory pool, whereas KLRG1+CD127low cells are viewed as short-lived effectors. Nevertheless, we and others have shown that a KLRG1+CD127low population persists into the memory phase and that these T cells (termed long-lived effector cells [LLEC]) display robust protective function during acute rechallenge with bacteria or viruses. Whether these T cells represent a true memory population or are instead a remnant effector cell population that failed to undergo initial contraction has remained unclear. In this study, we show that LLEC from mice express a distinct phenotypic and transcriptional signature that shares characteristics of both early effectors and long-lived memory cells. We also find that in contrast to KLRG1+ effector cells, LLEC undergo homeostatic proliferation and are not critically dependent on IL-15 for their maintenance. Furthermore, we find that LLEC are predominantly derived from KLRG1+ effector cells when isolated at day 12 of the response. Our work challenges the concept that the KLRG1+CD127low population is dominated by short-lived cells and shows that KLRG1 downregulation is not a prerequisite to become a long-lived protective memory T cell.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32611727      PMCID: PMC7415731          DOI: 10.4049/jimmunol.1901512

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.

Authors:  Nikhil S Joshi; Weiguo Cui; Anmol Chandele; Heung Kyu Lee; David R Urso; James Hagman; Laurent Gapin; Susan M Kaech
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

2.  KLRG1+ Effector CD8+ T Cells Lose KLRG1, Differentiate into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity.

Authors:  Dietmar Herndler-Brandstetter; Harumichi Ishigame; Ryo Shinnakasu; Valerie Plajer; Carmen Stecher; Jun Zhao; Melanie Lietzenmayer; Lina Kroehling; Akiko Takumi; Kohei Kometani; Takeshi Inoue; Yuval Kluger; Susan M Kaech; Tomohiro Kurosaki; Takaharu Okada; Richard A Flavell
Journal:  Immunity       Date:  2018-04-03       Impact factor: 31.745

3.  The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets.

Authors:  Cliff Y Yang; J Adam Best; Jamie Knell; Edward Yang; Alison D Sheridan; Adam K Jesionek; Haiyan S Li; Richard R Rivera; Kristin Camfield Lind; Louise M D'Cruz; Stephanie S Watowich; Cornelis Murre; Ananda W Goldrath
Journal:  Nat Immunol       Date:  2011-11-06       Impact factor: 25.606

Review 4.  Understanding Subset Diversity in T Cell Memory.

Authors:  Stephen C Jameson; David Masopust
Journal:  Immunity       Date:  2018-02-20       Impact factor: 31.745

5.  Effector-like CD8⁺ T cells in the memory population mediate potent protective immunity.

Authors:  Janelle A Olson; Cameron McDonald-Hyman; Stephen C Jameson; Sara E Hamilton
Journal:  Immunity       Date:  2013-06-06       Impact factor: 31.745

Review 6.  Transcriptional control of effector and memory CD8+ T cell differentiation.

Authors:  Susan M Kaech; Weiguo Cui
Journal:  Nat Rev Immunol       Date:  2012-10-19       Impact factor: 53.106

7.  Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells.

Authors:  Yun Ji; Zoltan Pos; Mahadev Rao; Christopher A Klebanoff; Zhiya Yu; Madhusudhanan Sukumar; Robert N Reger; Douglas C Palmer; Zachary A Borman; Pawel Muranski; Ena Wang; David S Schrump; Francesco M Marincola; Nicholas P Restifo; Luca Gattinoni
Journal:  Nat Immunol       Date:  2011-11-06       Impact factor: 25.606

8.  Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection.

Authors:  Kyla D Omilusik; J Adam Best; Bingfei Yu; Steven Goossens; Alexander Weidemann; Jessica V Nguyen; Eve Seuntjens; Agata Stryjewska; Christiane Zweier; Rahul Roychoudhuri; Luca Gattinoni; Lynne M Bird; Yujiro Higashi; Hisato Kondoh; Danny Huylebroeck; Jody Haigh; Ananda W Goldrath
Journal:  J Exp Med       Date:  2015-10-26       Impact factor: 14.307

9.  Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress.

Authors:  Tal I Arnon; Robert M Horton; Irina L Grigorova; Jason G Cyster
Journal:  Nature       Date:  2012-12-23       Impact factor: 49.962

10.  The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection.

Authors:  Claudia X Dominguez; Robert A Amezquita; Tianxia Guan; Heather D Marshall; Nikhil S Joshi; Steven H Kleinstein; Susan M Kaech
Journal:  J Exp Med       Date:  2015-10-26       Impact factor: 14.307

View more
  13 in total

1.  Delineation of a molecularly distinct terminally differentiated memory CD8 T cell population.

Authors:  J Justin Milner; Hongtuyet Nguyen; Kyla Omilusik; Miguel Reina-Campos; Matthew Tsai; Clara Toma; Arnaud Delpoux; Brigid S Boland; Stephen M Hedrick; John T Chang; Ananda W Goldrath
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-25       Impact factor: 11.205

2.  The Extracellular ATP Receptor P2RX7 Imprints a Promemory Transcriptional Signature in Effector CD8+ T Cells.

Authors:  Trupti Vardam-Kaur; Sarah van Dijk; Changwei Peng; Kelsey M Wanhainen; Stephen C Jameson; Henrique Borges da Silva
Journal:  J Immunol       Date:  2022-03-09       Impact factor: 5.426

3.  Single-Cell Transcriptomics Reveals Core Regulatory Programs That Determine the Heterogeneity of Circulating and Tissue-Resident Memory CD8+ T Cells.

Authors:  Yao Chen; Jian Shen; Moujtaba Y Kasmani; Paytsar Topchyan; Weiguo Cui
Journal:  Cells       Date:  2021-08-20       Impact factor: 7.666

Review 4.  Metabolic regulation of tissue-resident memory CD8+ T cells.

Authors:  Trupti Vardam-Kaur; Jie Sun; Henrique Borges da Silva
Journal:  Curr Opin Pharmacol       Date:  2021-03-11       Impact factor: 5.547

5.  Complex Interplay Between MAZR and Runx3 Regulates the Generation of Cytotoxic T Lymphocyte and Memory T Cells.

Authors:  Alexandra Franziska Gülich; Ramona Rica; Caroline Tizian; Csilla Viczenczova; Kseniya Khamina; Thomas Faux; Daniela Hainberger; Thomas Penz; Remy Bosselut; Christoph Bock; Asta Laiho; Laura L Elo; Andreas Bergthaler; Wilfried Ellmeier; Shinya Sakaguchi
Journal:  Front Immunol       Date:  2021-03-17       Impact factor: 7.561

6.  The architectural design of CD8+ T cell responses in acute and chronic infection: Parallel structures with divergent fates.

Authors:  H Kay Chung; Bryan McDonald; Susan M Kaech
Journal:  J Exp Med       Date:  2021-04-05       Impact factor: 14.307

7.  Sirtuin 5 is Dispensable for CD8+ T Cell Effector and Memory Differentiation.

Authors:  Qianqian Duan; Jiying Ding; Fangfang Li; Xiaowei Liu; Yunan Zhao; Hongxiu Yu; Yong Liu; Lianjun Zhang
Journal:  Front Cell Dev Biol       Date:  2021-12-13

8.  Longitudinal Characterization of the Mumps-Specific HLA-A2 Restricted T-Cell Response after Mumps Virus Infection.

Authors:  Josien Lanfermeijer; Marieke M Nühn; Maarten E Emmelot; Martien C M Poelen; Cécile A C M van Els; José A M Borghans; Debbie van Baarle; Patricia Kaaijk; Jelle de Wit
Journal:  Vaccines (Basel)       Date:  2021-12-03

9.  NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant.

Authors:  Harry Pickering; Subha Sen; Janice Arakawa-Hoyt; Kenichi Ishiyama; Yumeng Sun; Rajesh Parmar; Richard S Ahn; Gemalene Sunga; Megan Llamas; Alexander Hoffmann; Mario Deng; Suphamai Bunnapradist; Joanna M Schaenman; David W Gjertson; Maura Rossetti; Lewis L Lanier; Elaine F Reed
Journal:  JCI Insight       Date:  2021-11-08

10.  Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AML.

Authors:  F Brauneck; F Haag; R Woost; N Wildner; E Tolosa; A Rissiek; G Vohwinkel; J Wellbrock; C Bokemeyer; J Schulze Zur Wiesch; C Ackermann; W Fiedler
Journal:  Oncoimmunology       Date:  2021-06-21       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.